Foamix Pharmaceuticals (FOMX) Prices 6.7M IPO at $6/Share

September 18, 2014 9:28 AM EDT Send to a Friend
Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing its proprietary topical foams ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login